Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 2 publications
Multicenter validation of an RNA-based assay to predict anti-PD-1 disease control in patients with recurrent or metastatic head and neck squamous cell carcinoma: the PREDAPT study.
Journal: Journal for immunotherapy of cancer
Published: October 05, 2024
Multidimensional biomarker predicts disease control in response to immunotherapy in recurrent or metastatic head and neck squamous-cell carcinoma.
Journal: Journal of cancer research and clinical oncology
Published: June 26, 2023
Showing 1-2 of 2
Last Updated: 09/26/2026